IR and M&A Associate

As a Mergers & Acquisitions (M&A) and Investor Relations (IR) Associate, you play a crucial role in executing M&A transactions (divestitures and acquisitions) as well as maintaining relationships with our investors, shareholders and equity research analysts. Your main task is to prepare accurate and timely analyses and reports for the Head of M&A and IR, the CFO and the CEO of the company. You keep up to date with market trends, investor and corporate strategies, as well as current share price developments.

IR and M&A Associate | 80 - 100%

Ref no. 8189

Workplace: Burgdorf | Hybrid

Your main tasks

• Developing an in-depth understanding of Ypsomed’s strategy, business model, equity story and financial results
• Analysing industry trends, market data and competitors’ business development
• Preparing communication of half-year and annual figures as well as other capital market-oriented materials and events (including logistics, flight and hotel bookings)
• Assisting in the timely, professional response to enquiries from investors and sell-side equity research analysts
• Maintaining investor and target company databases
• Analysing teasers and information memoranda as well as preparing business cases, valuation analyses and transaction structures for M&A projects (DCF, market and transaction multiple analyses)
• Supporting Ypsomed’s finance and strategy teams such as Treasury, FP&A and Market Intelligence

Your profile

• Master’s degree in finance, business administration or economics
• 2–4 years of experience in corporate finance, M&A, equity research or investor relations; experience in strategy and controlling/FP&A is an advantage
• Excellent communication skills in English (C1) and German (C1), preferably German at native level
• Very good analytical skills as well as a pragmatic and solution-oriented working style
• Experience in a pharmaceutical or MedTech company is desirable
• Team player with enthusiasm for working in a dynamic, international environment

Ypsomed – Self-treatment becomes a matter of course

Ypsomed is a leading developer and manufacturer of injection systems for the self-administration of liquid medicines. For over 40 years, the company has been a reliable partner to the pharmaceutical and biotech industries – with solutions precisely tailored to the needs of its customers. Ypsomed has a proven track record and offers the most comprehensive and innovative platform portfolio for pens, autoinjectors and on-body devices. The solutions impress with the highest implementation quality and can be seamlessly integrated into digital health offerings. They support simpler therapy and thus contribute to a better quality of life for people with chronic diseases.

Ypsomed is headquartered in Burgdorf (Switzerland) and operates a global network of production sites. Over 2,000 employees worldwide are committed daily to making self-treatment a matter of course.

Contact

Alain Rusconi
Workforce Acquisition & Engagement Partner

Your future workplace

Burgdorf